Health-related quality of life in patients with rheumatic diseases taking tramadol 37.5mg/acetaminophen 325mg tablets; multicenter, open-label, prospective, observational study
Phase of Trial: Phase IV
Latest Information Update: 16 Jun 2014
At a glance
- Drugs Tramadol/paracetamol (Primary)
- Indications Musculoskeletal pain; Rheumatic disorders
- Focus Therapeutic Use
- Sponsors Janssen
- 02 Sep 2009 Actual initiation date (Sep 2007) added and planned number of patients changed from 1100 to 982 as reported by ClinicalTrials.gov.
- 02 Sep 2009 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 02 Sep 2009 Actual end date (May 2008) added as reported by ClinicalTrials.gov.